Liver transplantation: Selection, listing criteria, and preoperative management

Clinics in Liver Disease

Volumn 4, Issue 3, 2000, Pages 513-532

  Saab, Sammy ^b   Han, Steven Huy ^b   Martin, Paul ^b  

^a UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PERITONITIS; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MORBIDITY; OSTEOPOROSIS; PATIENT SELECTION; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; REVIEW; SURVIVAL;

EID: 0033869234     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70124-0     Document Type: Article

References (138)

1. E.A. Akriviadis B.A. Runyon Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis Gastroenterology 98 1990 127 133
2. P. Amodio F. Del Piccolo P. Marchetti Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests Hepatology 29 1999 1662 1667
3. M. Andreu R. Sola A. Sitges-Serra Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites Gastroenterology 104 1993 1133 1138
4. M.R. Antillon B.A. Runyon Postparacentesis plasma expansion prevents asymptomatic laboratory abnormalities, but does it have any impact on morbidity or mortality? Gastroenterology 101 1991 1455 1457
5. V. Arroyo P. Gines A.L. Gerbes Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club Hepatology 23 1996 164 176
6. V. Arroyo P. Gines R. Planas Treatment of ascites in cirrhosis: Diuretics, peritoneovenous shunt, and large-volume paracentesis Gastroenterol Clin North Am 21 1992 237 256
7. S. Badalamenti G. Graziani F. Salerno Hepatorenal syndrome. New perspectives in pathogenesis and treatment Arch Intern Med 153 1993 1957 1967
8. G. Barbaro G. Di Lorenzo M. Soldini Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study Hepatology 28 1998 374 378
9. L. Barbara G. Benzi S. Gaiani Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival Hepatology 16 1992 132 137
10. N.V. Bergasa D.W. Alling T.L. Talbot Effects of naloxone infusions in patients with the pruritus of cholestasis: A double-blind, randomized, controlled trial Ann Intern Med 123 1995 161 167
11. M. Blaise D. Pateron J.C. Trinchet Systemic antibiotic therapy prevents bacterial injections in cirrhotic patients with gastrointestinal hemorrhage Hepatology 20 1994 34 38
12. A.T. Blei Hepatic encephalopathy J. Bircher Benhamou J.P. McIntyre N. Rizzetto M. Rodes J. Oxford Textbook of Clinical Hepatology ed 2 1999 Oxford University Press Oxford 765 786
13. N.V. Bergasa E.A. Jones Management of the pruritus of cholestasis: Potential role of opiate antagonists Am J Gastroenterol 86 1991 1404 1412
14. N.V. Bergasa E.A. Jones The pruritus of cholestasis Semin Liver Dis 13 1993 319 327
15. N.V. Bergasa E.A. Jones The pruritus of cholestasis: Potential pathogenic and therapeutic implications of opioids Gastroenterology 108 1995 1582
16. N.V. Bergasa J.M. Schmitt T.L. Talbot Open-label trial of oral nalmefene therapy for the pruritus of cholestasis Hepatology 27 1998 679 684
17. N.V. Bergasa T.L. Talbot D.W. Alling A controlled trial of naloxone infusions for the pruritus of chronic cholestasis Gastroenterology 102 1992 544 549
18. T.D. Boyer P. Zia T.B. Reynolds Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease Gastroenterology 77 1979 215 222
19. J. Cabrera V. Arroyo A.M. Ballesta Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage Gastroenterology 82 1982 97 105
20. J.F. Cadranel M. el Younsi B. Pidoux Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: A double-blind pragmatic randomized, placebo study Eur J Gastroenterol Hepatol 7 1995 325 329
21. R.L. Carithers Jr Liver transplantation Liver Transpl Surg 6 1999 122 135
22. M. Castro M.J. Krowka Hepatopulmonary syndrome: A pulmonary vascular complication of liver disease Clin Chest Med 17 1996 35 48
23. Centers for Disease Control and Prevention General recommendations on immunization. Guidelines from the Immunization Practices Advisory Committee Ann Intern Med 111 1989 133 142
24. Centers for Disease Control and Prevention Web site Available at www.cdc.gov . Accessed February 1, 2000
25. M.R. Charlton Branched chains revisited Gastroenterology 111 1996 252 255
26. H.O. Conn C.M. Leevy Z.R. Vlahcevic Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy Gastroenterology 72 1977 573 583
27. J. Córdoba A.T. Blei Treatment of hepatic encephalopathy Am J Gastroenterol 92 1997 1429 1439
28. P.C. de Groen D.F. Lubbe L.J. Hirsch Esophagitis associated with the use of alendronate N Engl J Med 335 1996 1016 1021
29. A. Duchini M.E. Viernes L.M. Nyberg Hepatic decompensation in patients with cirrhosis during infection with influenza A Arch Intern Med 160 2000 113 115
30. C. Dupeyron N. Mangeney L. Sedrati Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis Antimicrob Agents Chemother 38 1994 340 344
31. M. Ebara M. Ohto T. Shinagawa Natural history of minute hepatocellular carcinoma smaller than thee centimeters complicating cirrhosis Gastroenterology 90 1986 289 298
32. G. Fattovich G. Giustina F. Degos Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients Gastroenterology 113 1997 463 472
33. V.A. Feldstein M.D. Patel J.M. LaBerge Transjugular intrahepatic portosystemic shunts: Accuracy of Doppler US in determination of patency and detection of stenoses Radiology 201 1996 141 147
34. P. Ferenci A. Herneth P. Steindal Newer approaches to therapy of hepatic encephalopathy Semin Liver Dis 16 1996 329 338
35. J.M. Fessel H.O. Conn An analysis of the causes and prevention of hepatic coma Gastroenterology 62 1972 191
36. T.L. Fong E.A. Akriviadis B.A. Runyon Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis Hepatology 9 1989 423 426
37. D. Franco J.L. Meakins A. Wu Long term results (greater than 5 years) in patients with peritoneovenous shunting for intractable ascites: liver function and cancer mortality HPB Surg 1989 1 1989 185 191
38. A.M. Freedman A.J. Sanyal J. Tisnado Complications of transjugular intrahepatic portosystemic shunt: A comprehensive review Radiographics 13 1993 1185 1210
39. J.T. Fulenwider J.D. Galambos R.B. Smith 3d LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis: A randomized, prospective trial Arch Surg 121 1986 351 355
40. C.N. Ghent S.G. Carruthers Treatment of pruritus in primary biliary cirrhosis with rifampin: Results of a double-blind, crossover, randomized trial Gastroenterology 94 1988 488 493
41. P. Gines V. Arroyo V. Vargas Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites N Engl J Med 325 1991 829 835
42. A. Gines A. Escorsell P. Gines Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis with ascites Gastroenterology 105 1993 229 236
43. A. Gines R. Planas P. Angeli Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: Comparison with therapeutic paracentesis Hepatology 22 1995 124 131
44. P. Gines A. Rimola R. Planas Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial Hepatology 12 1990 716 724
45. P. Gines L. Tito V. Arroyo Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis Gastroenterology 94 1988 1493 1502
46. J.D. Grange D. Roulot G. Pelletier Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: A double-blind randomized trial J Hepatol 29 1998 430 436
47. P.D. Greig B. Langer L.M. Blendis Complications after peritoneovenous shunting for ascites Am J Surg 139 1980 125 131
48. M. Groeneweg K. Gyr R. Amrein Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy: Results of a double blind, randomised, placebo-controlled multicentre trial Electroencephalogr Clin Neurophysiol 98 1996 29 34
49. M. Guevara P. Gines J.C. Bandi Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems Hepatology 28 1998 416 422
50. M. Guevara P. Gines G. Fernandez-Esparrach Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion Hepatology 27 1998 35 41
51. K. Gyr R. Meier J. Haussler Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: A double blind, randomised, placebo controlled multicentre study Gut 39 1996 319 324
52. J. Heathcote The pruritus of cholestasis is relieved by an opiate antagonist: Is this pruritus a centrally mediated phenomenon? Hepatology 23 1996 1280 1282
53. S. Hillaire M. Labianca G. Borgonovo Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure Surgery 113 1993 373 379
54. W.E. Hopkins A.D. Waggoner B. Barzilai Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease Am J Cardiol 70 1992 516 519
55. J. Inadomi A. Sonnenberg Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis Gastroenterology 114 1997 1289 1294
56. H. Isobe Y. Imari H. Sakai Subcutaneous seeding of hepatocellular carcinoma following fine-needle aspiration biopsy J Clin Gastroenterol 17 1993 350 352
57. E.A. Jones A.S. Basile C. Yurdaydin Do benzodiazepine ligands contribute to hepatic encephalopathy? Adv Exp Med Biol 341 1993 57 69
58. E.A. Jones N.V. Bergasa The pruritus of cholestasis: from bile acids to opiate agonists Hepatology 11 1990 884 887
59. J.A. Jorge-Hernandez C.E. Gonzalez-Reimers A. Torres-Ramirez Bone changes in alcoholic liver cirrhosis: A histomorphometrical analysis of 52 cases Dig Dis Sci 33 1988 1089 1095
60. P.S. Kamath M.A. McKusick Transvenous intrahepatic portosystemic shunts Gastroenterology 111 1996 1700 1705
61. T. Kanematsu N. Koyanagi T. Matsumata Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: A randomized, prospective trial Surgery 104 1988 482 488
62. R.Y. Kanterman M.D. Darcy W.D. Middleton Doppler sonography findings associated with transjugular intrahepatic portosystemic shunt malfunction AJR Am J Roentgenol 168 1997 467 472
63. E.B. Keeffe Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 90 1995 201 205
64. E.B. Keeffe S. Iwarson B.J. McMahon Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease Hepatology 27 1998 881 886
65. R.K. Kerlan Jr J.M. LaBerge R.L. Gordon Transjugular intrahepatic portosystemic shunts: Current status AJR Am J Roentgenol 164 1995 1059 1066
66. W.C. Ko Y.C. Chuang G.C. Huang Infections due to non-O1 Vibrio cholerae in southern Taiwan: Predominance in cirrhotic patients Clin Infect Dis 27 1998 774 780
67. M.J. Krowka D.A. Cortese Pulmonary aspects of liver disease and liver transplantation Clin Chest Med 10 1989 593 616
68. M.J. Krowka D.A. Cortese Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation Hepatology 11 1990 138 142
69. M.J. Krowka E.R. Dickson D.A. Cortese Hepatopulmonary syndrome: Clinical observations and lack of therapeutic response to somatostatin analogue Chest 104 1993 515 521
70. M.J. Krowka M.K. Porayko D.J. Plevak Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: Case reports and literature review Mayo Clin Proc 72 1997 44 53
71. M.J. Krowka A.J. Tajik E.R. Dickson Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates: Screening by two-dimensional contrast-enhanced echocardiography Chest 97 1990 1165 1170
72. P.A. Lange J.K. Stoller The hepatopulmonary syndrome: Effect of liver transplantation Clin Chest Med 17 1996 115 124
73. P.A. Lange J.K. Stoller The hepatopulmonary syndrome Ann Intern Med 122 1995 521 529
74. D. Lebrec N. Giuily A. Hadengue Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial. French Group of Clinicians and a Group of Biologists J Hepatol 25 1996 135 144
75. Y.F. Liaw D.I. Tai T.J. Chen Alpha-fetoprotein changes in the course of chronic hepatitis: Relation to bridging hepatic necrosis and hepatocellular carcinoma Liver 6 1986 133 137
76. C.J. Lin C.T. Chiu D.Y. Lin Non-O1 Vibrio cholerae bacteremia in patients with cirrhosis: 5-yr experience from a single medical center Am J Gastroenterol 91 1996 336 340
77. S.L. Linas J.W. Schaefer E.E. Moore Peritoneovenous shunt in the management of the hepatorenal syndrome Kidney Int 30 1986 736 740
78. J. Llach A. Rimola M. Navasa Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration Hepatology 16 1992 724 727
79. J.M. Llovet P. Rodriguez-Iglesias E. Moitinho Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination: A retrospective study of 229 spontaneous bacterial peritonitis episodes J Hepatol 26 1997 88 95
80. M.R. Lucey K.A. Brown G.T. Everson Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases Liver Transpl Surg 3 1997 628 637
81. G. Maconi G.B. Porro Multiple ulcerative esophagitis caused by alendronate Am J Gastroenterol 90 1995 1889 1890
82. Y. Matsuzaki N. Tanaka T. Osuga Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis Am J Gastroenterol 85 1990 15 23
83. P. Martin Hepatocellular carcinoma: risk factors and natural history Liver Transpl Surg 4 suppl 1998 S87 S91
84. B.J. McMahon L. Bulkow A. Harpster Early detection of hepatocellular carcinoma in HBsAg-positive carriers: A 15 year prospective population-based study in Alaska Hepatology 28 1998 388A
85. W.J. Miller M.P. Federle W.L. Campbell Diagnosis and staging of hepatocellular carcinoma: comparison of CT and sonography in 36 liver transplantation patients Am J Roentgenol 157 1991 303 306
86. A. Monegal M. Navasa N. Guanabens Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation Calcif Tissue Int 60 1997 148 154
87. R.D. Moore C.R. Smith P.S. Lietman Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides Am J Med 80 1986 1093 1097
88. M. Moskovitz The peritoneovenous shunt: expectations and reality Am J Gastroenterol 85 1990 917 929
89. C.D. Naylor K. O'Rourke A.S. Detsky Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: A meta-analysis Gastroenterology 97 1989 1033 1042
90. M. Novella R. Sola G. Soriano Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin Hepatology 25 1997 532 536
91. K. Ohtomo Y. Itai S. Furui Hepatic tumors: differentiation by transverse relaxation time (T2) of magnetic resonance imaging Radiology 155 1985 421 423
92. H. Oka A. Tamori T. Kuroki Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma Hepatology 19 1994 61 66
93. A. Pauwels N. Mostefa-Kara B. Debenes Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection Hepatology 24 1996 802 806
94. G. Pinzello R.G. Simonetti A. Craxi Spontaneous bacterial peritonitis: A prospective investigation in predominantly nonalcoholic cirrhotic patients Hepatology 3 1983 545 549
95. R. Planas P. Gines V. Arroyo Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis: Results of a randomized study Gastroenterology 99 1990 1736 1744
96. P.J. Pockros T.B. Reynolds Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema Gastroenterology 90 1986 1827 1833
97. A. Podesta P. Lopez R. Terg Treatment of pruritus of primary biliary cirrhosis with rifampin Dig Dis Sci 36 1991 216 220
98. J.E. Poulos M. Cancio P. Conrad Non 0-1 Vibrio cholerae septicemia and culture negative neutrocytic ascites in a patient with chronic liver disease J Fla Med Assoc 81 1994 676 678
99. R.W.H. Pugh I.M. Murray-Lyon J.L. Dawson Transection of the esophagus for bleeding esophageal varices: Final analysis of a controlled trial Br J Surg 60 1983 646 649
100. J.C. Quero S.W. Schalm Subclinical hepatic encephalopathy Semin Liver Dis 16 1996 321 328
101. T.B. Reynolds F.L. Lieberman A.G. Redeker Functional renal failure with cirrhosis. The effect of plasma expansion therapy Medicine (Baltimore) 46 1967 191 196
102. A. Rolachon L. Cordier Y. Bacq Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: Results of a prospective controlled trial Hepatology 22 1995 1171 1174
103. H.R. Rosen C.R. Shackleton P. Martin Indications for and timing of liver transplantation Med Clin North Am 80 1996 1069 1102
104. B.A. Runyon Paracentesis of ascitic fluid: A safe procedure Arch Intern Med 146 1986 2259 2261
105. B.A. Runyon Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis Gastroenterology 91 1986 1343 1346
106. B.A. Runyon Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis Hepatology 12 1990 710 715
107. B.A. Runyon Albumin infusion for spontaneous bacterial peritonitis Lancet 354 1999 1838 1839
108. B.A. Runyon Management of adult patients with ascites caused by cirrhosis Hepatology 27 1998 264 272
109. B.A. Runyon M.R. Antillon E.A. Akriviadis Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis J Clin Microbiol 28 1990 2811 2812
110. B.A. Runyon J.C. Hoefs Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid Hepatology 4 1984 447 450
111. B.A. Runyon J.G. McHutchison M.R. Antillon Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis: A randomized controlled study of 100 patients Gastroenterology 100 1991 1737 1742
112. B.A. Runyon E.T. Umland T. Merlin Inoculation of blood culture bottles with ascitic fluid. Improved detection of spontaneous bacterial peritonitis Arch Intern Med 147 1987 73 75
113. A.J. Sanyal The management of the cirrhotic patient after transjugular intrahepatic portosystemic shunt Semin Gastrointest Dis 8 1997 188 199
114. A.J. Sanyal A.M. Freedman V.A. Luketic Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: A randomized, controlled trial Ann Intern Med 126 1997 849 857
115. A.J. Sanyal A.M. Freedman V.A. Luketic The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts Gastroenterology 112 1997 889 898
116. M. Sherman K.M. Peltekian C. Lee Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population Hepatology 22 1995 432 438
117. J.C. Sheu J.L. Sung D.S. Chen Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications Gastroenterology 89 1985 259 266
118. J.C. Sheu J.L. Sung D.S. Chen Early detection of hepatocellular carcinoma by real-time ultrasonography: A prospective study Cancer 56 1985 660 666
119. M.L. Shiffman L. Jeffers J.H. Hoofnagle The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board Hepatology 22 1995 1591 1597
120. N. Singh T. Gayowski V.L. Yu Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: A randomized trial Ann Intern Med 122 1995 595 598
121. G. Soriano C. Guarner M. Teixido Selective intestinal decontamination prevents spontaneous bacterial peritonitis Gastroenterology 100 1991 477 481
122. G. Soriano C. Guarner A. Tomas Norfloxacin prevents bacterial infection in cirrhosis with gastrointestinal hemorrhage Gastroenterology 103 1992 1267 1272
123. P. Sort M. Navasa V. Arroyo Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Eng J Med 341 1999 403 409
124. M.M. Stanley S. Ochi K.K. Lee Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites N Engl J Med 321 1989 1632 1638
125. K.M. Sterling M.D. Darcy Stenosis of transjugular intrahepatic portosystemic shunts: presentation and management AJR Am J Roentgenol 168 1997 239 244
126. L. Tito A. Rimola P. Gines Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors Hepatology 8 1988 21 31
127. C. Toledo J.M. Salmeron A. Rimola Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime Hepatology 17 1993 251 257
128. United Network for Organ Sharing Web site Available at www.unet.org . Accessed January 31, 2000
129. C.C. Van der Rijt S.W. Schalm J. Meulstee Flumazenil therapy for hepatic encephalopathy: A double-blind cross over study Gastroenterol Clin Biol 19 1995 572 580
130. D.H. Van Thiel Liver transplantation: A history of the past and present with a vision of the future W.C. Maddrey M.F. Sorrell Transplantation of the liver ed 2 1995 Appleton & Lange Norwalk, CT 1 12
131. S. Vento T. Garofano C. Renzini Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C N Engl J Med 338 1998 286 290
132. S.S. Wang Y.T. Tsai S.D. Lee Spontaneous bacterial peritonitis in patients with hepatitis B-related cirrhosis and hepatocellular carcinoma Gastroenterology 101 1991 545 549
133. F.H. Wolfhagen E. Sternieri W.C. Hop Oral naltrexone treatment for cholestatic pruritus: A double-blind, placebo-controlled study Gastroenterology 113 1997 1264 1269
134. G.M. Woolf T.B. Reynolds Failure of rifampin to relieve pruritus in chronic liver disease J Clin Gastroenterol 12 1990 174 177
135. Z.M. Younossi J.G. McHutchison T.G. Ganiats An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis J Hepatol 27 1997 295 298
136. R.D. Zipser J.C. Hoefs P.F. Speckart Prostaglandins: Modulators of renal function and pressor resistance in chronic liver disease J Clin Endocrinol Metab 48 1979 895 900
137. R.D. Zipser P. Kerlin J.C. Hoefs Renal kallikrein excretion in alcoholic cirrhosis: Relationship to other vasoactive systems Am J Gastroenterol 75 1981 183 187
138. M. Zoli D. Magalotti G. Bianchi Efficacy of a surveillance program for early detection of hepatocellular carcinoma Cancer 78 1996 977 985